
NYSE:UN
This summary was created by AI, based on 1 opinions in the last 12 months.
Unilever NV has received mixed reviews from various experts, largely focusing on significant changes in consumer behavior and the company's strategic decisions. Specifically, the introduction of GLP-1 drugs has altered diets, leading to a decline in processed food consumption, which could negatively impact Unilever's sales. Additionally, the merger with McCormick has been deemed a failure, raising concerns about Unilever's current focus and direction. With these factors taken into account, it appears that there are significant challenges ahead for the company. Recent assessments suggest that investors might want to tread cautiously before making new commitments to Unilever shares.
Nestle is better longer term proxy for this space. UN-N has been under-performing against it peers as they have been below guidance and have seen market share losses.
Trades at 20x earnings and pays a 3.4% yield. The problem is that Kraft wanted to buy them. Unilever reacted by restructuring, but did so poorly. They are cutting investments to meet their targets, which is not a good move. Another problem is that they won't sell unprofitable parts of their business. Third, they are using their balance sheet to buy businesses instead of re-structuring properly. They're in a lot tougher business now than years ago, given online/social media branding.
He is not bullish on consumer stocks. They have been losing pricing power. Unilever has great brands but the ecommerce move is making it difficult for FMCG (fast-moving consumer goods) companies, putting more pricing pressure on them. It has become very easy to build new cosmetic brands and these new boutique brands will add pressure on companies like Unilever.